Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 71610-205 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 500 mg - 71610 0205 30
![71610-0205-30.jpg Bottle Label 500 mg - 71610 0205 30](https://ndclist.com/assets/spl/images/177e34e9-f74d-42aa-8e3c-5fb4f41c2322/400x-71610-0205-30.jpg)
This is a medication package label for Divatproex Sodium ER tablets, USP, containing 30 tablets, with a serial number and lot number specified. The package also has a manufacturing date of February 2020.*
Figure 1 - divalproex fig1
![divalproex-fig1.jpg Figure 1 - divalproex fig1](https://ndclist.com/assets/spl/images/177e34e9-f74d-42aa-8e3c-5fb4f41c2322/400x-divalproex-fig1.jpg)
The text is a figure caption for an image labeled "Figure 1", presenting the reduction in CPS rate for Divalproex Sodium Delayed-Release Tablets compared to a placebo in a group of patients. The figure shows that 50% of the patients experienced an improvement.*
Figure 2 - divalproex fig2
![divalproex-fig2.jpg Figure 2 - divalproex fig2](https://ndclist.com/assets/spl/images/177e34e9-f74d-42aa-8e3c-5fb4f41c2322/400x-divalproex-fig2.jpg)
The text is a diagram showing the reduction in CPS rates for patients taking high and low doses of Divalproex Sodium Delayed-Release Tablets. It indicates that 50% of patients experienced improvement, while some experienced no change and others worsening of their condition.*
figure-3 - divalproex fig3
![divalproex-fig3.jpg figure-3 - divalproex fig3](https://ndclist.com/assets/spl/images/177e34e9-f74d-42aa-8e3c-5fb4f41c2322/400x-divalproex-fig3.jpg)
This appears to be a mixture of numerical values, a single word, and a medication name "Divalproex Sodium Extended-Release Tablets". It is difficult to provide a useful description with this limited information, as there is no context or clear indication of the purpose of the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.